78 related articles for article (PubMed ID: 7700239)
1. Interaction between the nonpeptide angiotensin antagonist SKF-108,566 and histidine 256 (HisVI:16) of the angiotensin type 1 receptor.
Schambye HT; Hjorth SA; Weinstock J; Schwartz TW
Mol Pharmacol; 1995 Mar; 47(3):425-31. PubMed ID: 7700239
[TBL] [Abstract][Full Text] [Related]
2. Role of the His273 located in the sixth transmembrane domain of the angiotensin II receptor subtype AT2 in ligand-receptor interaction.
Turner CA; Cooper S; Pulakat L
Biochem Biophys Res Commun; 1999 Apr; 257(3):704-7. PubMed ID: 10208847
[TBL] [Abstract][Full Text] [Related]
3. Interaction of biphenylimidazole and imidazoleacrylic acid nonpeptide antagonists with valine 108 in TM III of the AT1 angiotensin receptor.
Nirula V; Zheng W; Sothinathan R; Sandberg K
Br J Pharmacol; 1996 Dec; 119(8):1505-7. PubMed ID: 8982494
[TBL] [Abstract][Full Text] [Related]
4. Identification of nonconserved amino acids in the AT1 receptor which comprise a general binding site for biphenylimidazole antagonists.
Nirula V; Zheng W; Krishnamurthi K; Sandberg K
FEBS Lett; 1996 Oct; 394(3):361-4. PubMed ID: 8830675
[TBL] [Abstract][Full Text] [Related]
5. Differentiation between binding sites for angiotensin II and nonpeptide antagonists on the angiotensin II type 1 receptors.
Schambye HT; Hjorth SA; Bergsma DJ; Sathe G; Schwartz TW
Proc Natl Acad Sci U S A; 1994 Jul; 91(15):7046-50. PubMed ID: 8041743
[TBL] [Abstract][Full Text] [Related]
6. Amino acids of the third transmembrane domain of the AT1A angiotensin II receptor are involved in the differential recognition of peptide and nonpeptide ligands.
Groblewski T; Maigret B; Nouet S; Larguier R; Lombard C; Bonnafous JC; Marie J
Biochem Biophys Res Commun; 1995 Apr; 209(1):153-60. PubMed ID: 7726829
[TBL] [Abstract][Full Text] [Related]
7. The clinical profile of the angiotensin II receptor blocker eprosartan.
Hedner T
J Hypertens Suppl; 2002 Jun; 20(5):S33-8. PubMed ID: 12184062
[TBL] [Abstract][Full Text] [Related]
8. Interaction of Phe8 of angiotensin II with Lys199 and His256 of AT1 receptor in agonist activation.
Noda K; Saad Y; Karnik SS
J Biol Chem; 1995 Dec; 270(48):28511-4. PubMed ID: 7499361
[TBL] [Abstract][Full Text] [Related]
9. Identification of peptide binding residues in the extracellular domains of the AT1 receptor.
Hjorth SA; Schambye HT; Greenlee WJ; Schwartz TW
J Biol Chem; 1994 Dec; 269(49):30953-9. PubMed ID: 7983030
[TBL] [Abstract][Full Text] [Related]
10. Differential structural requirements for specific binding of nonpeptide and peptide antagonists to the AT1 angiotensin receptor. Identification of amino acid residues that determine binding of the antihypertensive drug losartan.
Ji H; Leung M; Zhang Y; Catt KJ; Sandberg K
J Biol Chem; 1994 Jun; 269(24):16533-6. PubMed ID: 8206967
[TBL] [Abstract][Full Text] [Related]
11. Properties of [3H]LF 7-0156, a new nonpeptide antagonist radioligand for the type 1 angiotensin II receptor.
Nouet S; Dodey P; Renaut P; Marie J; Pruneau D; Larguier R; Lombard C; Bonnafous JC
Mol Pharmacol; 1994 Oct; 46(4):693-701. PubMed ID: 7969048
[TBL] [Abstract][Full Text] [Related]
12. An update on non-peptide angiotensin receptor antagonists and related RAAS modulators.
Aulakh GK; Sodhi RK; Singh M
Life Sci; 2007 Aug; 81(8):615-39. PubMed ID: 17692338
[TBL] [Abstract][Full Text] [Related]
13. Non-peptide angiotensin agonist. Functional and molecular interaction with the AT1 receptor.
Perlman S; Schambye HT; Rivero RA; Greenlee WJ; Hjorth SA; Schwartz TW
J Biol Chem; 1995 Jan; 270(4):1493-6. PubMed ID: 7829475
[TBL] [Abstract][Full Text] [Related]
14. Residues Val254, His256, and Phe259 of the angiotensin II AT1 receptor are not involved in ligand binding but participate in signal transduction.
Han HM; Shimuta SI; Kanashiro CA; Oliveira L; Han SW; Paiva AC
Mol Endocrinol; 1998 Jun; 12(6):810-4. PubMed ID: 9626656
[TBL] [Abstract][Full Text] [Related]
15. Functional studies but not receptor binding can distinguish surmountable from insurmountable AT1 antagonism.
Panek RL; Lu GH; Overhiser RW; Major TC; Hodges JC; Taylor DG
J Pharmacol Exp Ther; 1995 May; 273(2):753-61. PubMed ID: 7752078
[TBL] [Abstract][Full Text] [Related]
16. Imidazole based non-peptide angiotensin II receptor antagonists. Investigation of the effect of the orientation of the imidazole ring on biological activity.
Wahhab A; Smith JR; Ganter RC; Moore DM; Hondrelis J; Matsoukas J; Moore GJ
Arzneimittelforschung; 1993 Nov; 43(11):1157-68. PubMed ID: 8292058
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin type 1 receptors mediate smooth muscle proliferation and endothelin biosynthesis in rat vascular smooth muscle.
Sung CP; Arleth AJ; Storer BL; Ohlstein EH
J Pharmacol Exp Ther; 1994 Oct; 271(1):429-37. PubMed ID: 7965744
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological mechanism of angiotensin II receptor antagonists: implications for the treatment of elevated systolic blood pressure.
Brooks DP; Ruffolo RR
J Hypertens Suppl; 1999 Jun; 17(2):S27-32. PubMed ID: 10465064
[TBL] [Abstract][Full Text] [Related]
19. Role of Arg182 in the second extracellular loop of angiotensin II receptor AT2 in ligand binding.
Kurfis J; Knowle D; Pulakat L
Biochem Biophys Res Commun; 1999 Oct; 263(3):816-9. PubMed ID: 10512763
[TBL] [Abstract][Full Text] [Related]
20. Lys(199) mutation of the human angiotensin type 1 receptor differentially affects the binding of surmountable and insurmountable non-peptide antagonists.
Fierens FL; Vanderheyden PM; Gáborik Z; Minh TL; Backer JP; Hunyady L; Ijzerman A; Vauquelin G
J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):283-8. PubMed ID: 11881039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
